This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on may 25, 2018.(b)(4).The molded pulp was returned and confirmed to have profanity written on it.The oxygenator in question was tracked through product and into packaging.Molded pulp product is received in plastic shrink wrap on a pallet from the supplier and remains that way until brought into packaging for production use.The recordings from the cameras in the packaging room were reviewed, and was monitored by three members of the management.There was no indications that the profanity was written at tcvs.The investigation was shifted to the supplier of the molded pulp.Their investigation determined that the issue stemmed from a disgruntled employee who is no longer with them.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|